These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22578953)

  • 1. Effectiveness of statin therapy for elderly acute myocardial infarction patients with normal levels of low-density lipoprotein cholesterol.
    Yamanaka F; Jeong MH; Saito S; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ
    Int J Cardiol; 2012 Jun; 158(1):139-43. PubMed ID: 22578953
    [No Abstract]   [Full Text] [Related]  

  • 2. Superior short-term cholesterol control and achievement of the adult treatment panel III low-density lipoprotein goals with initiation of statin therapy by the time of hospital discharge following acute myocardial infarction.
    Bybee KA; Powell BD; Williams BA; Murphy JG; Kopecky SL; Wright RS
    Am J Cardiol; 2004 Mar; 93(6):776-9. PubMed ID: 15019892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
    Wiviott SD; Cannon CP; Morrow DA; Ray KK; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1411-6. PubMed ID: 16226163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of early statin therapy for patients with acute myocardial infarction treated with stent implantation.
    Kadota S; Matsuda M; Izuhara M; Baba O; Moriwaki S; Shioji K; Takeuchi Y; Uegaito T
    J Cardiol; 2008 Jun; 51(3):171-8. PubMed ID: 18522792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study.
    Olsson AG; Lindahl C; Holme I; Fayyad R; Faergeman O; Kastelein JJ; Tikkanen MJ; Larsen ML; Pedersen TR;
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):262-9. PubMed ID: 21450674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein levels and outcomes after statin therapy.
    Jaber BL; Madias NE
    N Engl J Med; 2005 Apr; 352(15):1603-5; author reply 1603-5. PubMed ID: 15832451
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of statin treatment on mortality of patients with myocardial infarction.
    Vincze Z; Brugos B
    Pharmazie; 2012 May; 67(5):419-21. PubMed ID: 22764575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
    Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
    J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug insight: Statin use in the elderly.
    Raffel OC; White HD
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of Pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS]).
    Suh SY; Rha SW; Ahn TH; Shin EK; Choi CU; Oh DJ; Bae JH; Hur SH; Yun KH; Oh SK; Kim JH; Kim SW; Chae IH; Kim KS; Hong YJ; Jeong MH;
    Am J Cardiol; 2011 Dec; 108(11):1530-5. PubMed ID: 21890083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
    J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
    Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
    Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.